Cangzhou Senary Chemical S&T Co.,Ltd
- Business Type : Manufacturer
- Year Established : 2003
- Main Products : Donepezil HCL,Glimepiride
- Country/Region : China
- Links : China Health & Medicines, China Pharmaceutical Chemicals,
Company Introduction
Our company was founded in Feb. 2003. We are a private-owned pharmachemical developer, manufacturer and exporter.
Our company has been selected as "High and New Adwanced Technology Company in Hebei Province' in August 2005.Got the first place in select of the most potential technical minor enterprises which is held by Hebei Technology Bureau and Hebei Risk Investment Company in Nov.2005.
We mainly offer diabetes and cardiovascular AP Is and intermediates. By promising high quality consistency, timely delivery and good technical service, our products have been successfully accepted by customers worldwide and we have been a major provider of theses drug to some leading pharmaceutical companies in China.
Our core competence lies in our ability to rapidly carry out syntheses from lab scale to full commercial scale, and with optimization. Since the early days our company was founded, we have been focusing on development of synthesis technologies. We have adwanced labs, workshops and other indispensable facilities to make sure that all products we offer meet generally recognized standards.
We aim at being a better and more specialized pharmachemical manufacturers in the years to come. We bought a 6.6-hectare land in 2005 and plan to build a new, GMP-complied API manufacturing facility. Meanwhile, many of our products are undergoing ISO certification now.
Contact Information
- Contact Person : Yuki Lan
- Telephone : 86 - 317 - 3563899
- Fax Number : 86 - 317 - 3563199
- Address : 168#jinde road cangzhpu city hebei province china Cangzhou Hebei 061000 China
- Fax : 86 - 317 - 3563199
- Website : Visit website
Related Products:Cangzhou Senary Chemical S&T Co.,Ltd
No advertising and no spamming please
Cangzhou Senary Chemical S&T Co.,Ltd no reviews currently
No reviews currently, you may post the first one.